Cohort IMEA 070 -Lenacapavir Compassional - Trial NCT06289361
Access comprehensive clinical trial information for NCT06289361 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba and is currently Not yet recruiting. The study focuses on HIV Infections. Target enrollment is 58 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Timeline & Enrollment
N/A
Apr 01, 2024
Jul 30, 2024
Primary Outcome
proportion of participants with plasma HIV RNA 50 copies/ml 26 weeks after first LEN injection
Summary
Immunovirological follow-up and safety of HIV-infected patients receiving lenacapavir under
 compassionate access in France between 01/01/2021 and 12/31/2023
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06289361
Non-Device Trial

